Asia Pacific transradial access market is expected to USD 387.4 million by 2025 from USD 201.3 million in 2017, at the highest CAGR of 8.6% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Based on product the market is segmented into six notable segments; sheaths and sheath introducers, mircrocatheters, guidewires, guiding catheters, intermediate catheters and accessories. In 2018, sheaths and sheath introducers market is likely to dominate market and is estimated to with the highest CAGR in the forecast period.
On the basis of application the market is segmented into three notable segments; neurovascular, cardiology, and peripheral vascular. In 2018, cardiology market will dominate the market with the highest CAGR in the assessment period.
On the basis of usage the market is segmented into four notable segments; drug administration, fluid and nutrition administration, diagnostics and testing and blood transfusion. In 2018, the drug administration market is estimated to dominate the market and is estimated to with the highest CAGR in the forecast period.
On the basis of end user, the market is segmented into four notable segments; hospital, clinics, ambulatory care centers and others. In 2018, hospitals market is expected to dominate the market and is estimated to grow with the highest CAGR.
Based on geography, the market is segmented into11 geographical countries;
Japan
China
India
South Korea
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Vietnam
Rest of Asia Pacific


Asia Pacific transradial access market competition by top players include -
Cardinal Health dominated the core materials market accounting largest market share followed by Terumo Corporation and Angiodynamics Inc. along with other players such as
Stryker
BD
Teleflex Incorporated
Smiths Group plc
MEDTRONIC
Boston Scientific Corporation
Edwards Lifesciences Corporation
Merit Medical Systems Inc.
NIPRO CORPORATION
Amecath
OSCOR Inc.
Penumbra